MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL) has reported earnings 39 times since Mar 26, 2009. The stock moves an average of ±4.88% the day after reporting, closing higher 46.2% of the time. Its largest post-earnings gain was +20.1% (Oct 31, 2024) and its largest decline was -12.18% (Aug 07, 2024). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings reactions
How MDGL moved on each past earnings report.
Earnings Impact
Total Earnings
39
Avg Abs. Movement
±4.88%
Positive %
46.2%
Negative %
53.8%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 06, 2026 | ☀ PRE | +7.49% | open_in_new |
| Feb 19, 2026 | ☀ PRE | -11.11% | open_in_new |
| Nov 04, 2025 | ☀ PRE | +7.83% | open_in_new |
| Aug 05, 2025 | ☀ PRE | +8.59% | open_in_new |
Earnings Count
39
Total earnings in dataset
Avg Abs. Movement
±4.88%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260720 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 4 | 20260618 | open_in_new SEC.gov |
| 8-K | 20260617 | open_in_new SEC.gov |
| S-8 | 20260617 | open_in_new SEC.gov |
Frequently asked about MDGL earnings
When does MADRIGAL PHARMACEUTICALS, INC. report earnings next? expand_more
MADRIGAL PHARMACEUTICALS, INC. (MDGL)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does MDGL stock move after earnings? expand_more
Over 39 reports, MDGL has moved an average of ±4.88% the session after earnings, closing higher 46.2% of the time.
What was MDGL's biggest post-earnings move? expand_more
MDGL's largest post-earnings gain on record was +20.1% on Oct 31, 2024, and its largest decline was -12.18% on Aug 07, 2024.
Where can I find MADRIGAL PHARMACEUTICALS, INC.'s SEC filings? expand_more
All of MADRIGAL PHARMACEUTICALS, INC.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- Allegiant Travel CO (ALGT) earnings 2026-08-03
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arbutus Biopharma Corp (ABUS) earnings 2026-08-03
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04